AAPL338.40-2.67 (-0.78%) ▼|ABBV266.28+1.94 (+0.73%) ▲|ABT100.98-0.31 (-0.31%) ▼|ACN174.47-1.64 (-0.93%) ▼|ADBE231.01-4.46 (-1.89%) ▼|AMAT486.76+1.76 (+0.36%) ▲|AMD607.87-22.76 (-3.61%) ▼|AMGN418.13+3.52 (+0.85%) ▲|AMT168.00-1.03 (-0.61%) ▼|AMZN246.15-3.52 (-1.41%) ▼|AVGO349.57-3.24 (-0.92%) ▼|AXP306.33-2.56 (-0.83%) ▼|BA184.39-13.68 (-6.91%) ▼|BAC55.47-1.23 (-2.17%) ▼|BKNG163.87-0.08 (-0.05%) ▼|BLK1,071.25-15.06 (-1.39%) ▼|BMY63.88+1.02 (+1.62%) ▲|BNY148.44-1.71 (-1.14%) ▼|BRK-B503.09-2.39 (-0.47%) ▼|C131.31-2.97 (-2.21%) ▼|CAT819.95-1.63 (-0.20%) ▼|CL86.52+0.46 (+0.53%) ▲|CMCSA21.79-0.12 (-0.55%) ▼|COF196.46-3.74 (-1.87%) ▼|COP126.04-1.26 (-0.99%) ▼|COST922.92+0.16 (+0.02%) ▲|CRM227.27-6.75 (-2.88%) ▼|CSCO106.74+0.04 (+0.04%) ▲|CVS87.85-1.28 (-1.44%) ▼|CVX206.37+1.92 (+0.94%) ▲|DE689.59-0.87 (-0.13%) ▼|DHR227.33+2.84 (+1.27%) ▲|DIS105.59-0.56 (-0.53%) ▼|DUK113.41+0.06 (+0.05%) ▲|EMR159.39+1.16 (+0.73%) ▲|FDX289.65+3.80 (+1.33%) ▲|GD334.16-2.56 (-0.76%) ▼|GE318.24-8.85 (-2.71%) ▼|GEV949.77-7.86 (-0.82%) ▼|GILD152.21+1.28 (+0.85%) ▲|GM80.64-1.99 (-2.41%) ▼|GOOG339.16-1.92 (-0.56%) ▼|GOOGL342.75-1.17 (-0.34%) ▼|GS916.28-19.17 (-2.05%) ▼|HD289.89-3.31 (-1.13%) ▼|HON211.52-1.03 (-0.48%) ▼|IBM220.67-4.84 (-2.15%) ▼|INTC116.03-6.97 (-5.67%) ▼|INTU269.40-6.39 (-2.32%) ▼|ISRG414.79+9.61 (+2.37%) ▲|JNJ271.95+0.73 (+0.27%) ▲|JPM336.59-6.47 (-1.89%) ▼|KO87.18-0.63 (-0.72%) ▼|LIN472.04+2.15 (+0.46%) ▲|LLY1,184.78+1.32 (+0.11%) ▲|LMT518.10-1.46 (-0.28%) ▼|LOW187.66-1.62 (-0.86%) ▼|LRCX314.47-0.74 (-0.23%) ▼|MA568.26+0.61 (+0.11%) ▲|MCD233.60-2.90 (-1.23%) ▼|MDLZ60.18-0.07 (-0.12%) ▼|MDT89.50+0.86 (+0.97%) ▲|META715.62-36.04 (-4.79%) ▼|MMM169.48-0.07 (-0.04%) ▼|MO69.13+0.31 (+0.45%) ▲|MRK148.69-0.09 (-0.06%) ▼|MS193.64-2.67 (-1.36%) ▼|MSFT509.22-6.95 (-1.35%) ▼|MU1,053.98-28.30 (-2.61%) ▼|NEE75.49-0.59 (-0.78%) ▼|NFLX69.23-1.92 (-2.69%) ▼|NKE36.39+0.64 (+1.79%) ▲|NOW131.45-4.17 (-3.07%) ▼|NVDA228.86+3.79 (+1.68%) ▲|ORCL132.60-4.50 (-3.28%) ▼|PEP128.50-0.13 (-0.10%) ▼|PFE28.72+0.05 (+0.17%) ▲|PG149.03+2.80 (+1.91%) ▲|PLTR187.48-2.19 (-1.15%) ▼|PM193.76+3.28 (+1.72%) ▲|QCOM187.48-14.49 (-7.17%) ▼|RTX187.66-1.74 (-0.92%) ▼|SBUX95.27+0.41 (+0.43%) ▲|SCHW98.30-0.73 (-0.74%) ▼|SO82.35-0.53 (-0.64%) ▼|SPG204.53-0.29 (-0.14%) ▼|T24.90-0.48 (-1.89%) ▼|TMO678.60+3.60 (+0.53%) ▲|TMUS166.45+1.02 (+0.62%) ▲|TSLA357.45-14.66 (-3.94%) ▼|TXN278.31+0.24 (+0.09%) ▲|UBER68.16-1.46 (-2.10%) ▼|UNH377.83+1.24 (+0.33%) ▲|UNP274.10+0.31 (+0.11%) ▲|UPS94.25+0.29 (+0.31%) ▲|USB58.78-0.55 (-0.93%) ▼|V367.74+0.36 (+0.10%) ▲|VZ46.68-0.40 (-0.85%) ▼|WFC80.81-2.16 (-2.60%) ▼|WMT108.73+0.75 (+0.69%) ▲|XOM162.52+1.93 (+1.20%) ▲|AAPL338.40-2.67 (-0.78%) ▼|ABBV266.28+1.94 (+0.73%) ▲|ABT100.98-0.31 (-0.31%) ▼|ACN174.47-1.64 (-0.93%) ▼|ADBE231.01-4.46 (-1.89%) ▼|AMAT486.76+1.76 (+0.36%) ▲|AMD607.87-22.76 (-3.61%) ▼|AMGN418.13+3.52 (+0.85%) ▲|AMT168.00-1.03 (-0.61%) ▼|AMZN246.15-3.52 (-1.41%) ▼|AVGO349.57-3.24 (-0.92%) ▼|AXP306.33-2.56 (-0.83%) ▼|BA184.39-13.68 (-6.91%) ▼|BAC55.47-1.23 (-2.17%) ▼|BKNG163.87-0.08 (-0.05%) ▼|BLK1,071.25-15.06 (-1.39%) ▼|BMY63.88+1.02 (+1.62%) ▲|BNY148.44-1.71 (-1.14%) ▼|BRK-B503.09-2.39 (-0.47%) ▼|C131.31-2.97 (-2.21%) ▼|CAT819.95-1.63 (-0.20%) ▼|CL86.52+0.46 (+0.53%) ▲|CMCSA21.79-0.12 (-0.55%) ▼|COF196.46-3.74 (-1.87%) ▼|COP126.04-1.26 (-0.99%) ▼|COST922.92+0.16 (+0.02%) ▲|CRM227.27-6.75 (-2.88%) ▼|CSCO106.74+0.04 (+0.04%) ▲|CVS87.85-1.28 (-1.44%) ▼|CVX206.37+1.92 (+0.94%) ▲|DE689.59-0.87 (-0.13%) ▼|DHR227.33+2.84 (+1.27%) ▲|DIS105.59-0.56 (-0.53%) ▼|DUK113.41+0.06 (+0.05%) ▲|EMR159.39+1.16 (+0.73%) ▲|FDX289.65+3.80 (+1.33%) ▲|GD334.16-2.56 (-0.76%) ▼|GE318.24-8.85 (-2.71%) ▼|GEV949.77-7.86 (-0.82%) ▼|GILD152.21+1.28 (+0.85%) ▲|GM80.64-1.99 (-2.41%) ▼|GOOG339.16-1.92 (-0.56%) ▼|GOOGL342.75-1.17 (-0.34%) ▼|GS916.28-19.17 (-2.05%) ▼|HD289.89-3.31 (-1.13%) ▼|HON211.52-1.03 (-0.48%) ▼|IBM220.67-4.84 (-2.15%) ▼|INTC116.03-6.97 (-5.67%) ▼|INTU269.40-6.39 (-2.32%) ▼|ISRG414.79+9.61 (+2.37%) ▲|JNJ271.95+0.73 (+0.27%) ▲|JPM336.59-6.47 (-1.89%) ▼|KO87.18-0.63 (-0.72%) ▼|LIN472.04+2.15 (+0.46%) ▲|LLY1,184.78+1.32 (+0.11%) ▲|LMT518.10-1.46 (-0.28%) ▼|LOW187.66-1.62 (-0.86%) ▼|LRCX314.47-0.74 (-0.23%) ▼|MA568.26+0.61 (+0.11%) ▲|MCD233.60-2.90 (-1.23%) ▼|MDLZ60.18-0.07 (-0.12%) ▼|MDT89.50+0.86 (+0.97%) ▲|META715.62-36.04 (-4.79%) ▼|MMM169.48-0.07 (-0.04%) ▼|MO69.13+0.31 (+0.45%) ▲|MRK148.69-0.09 (-0.06%) ▼|MS193.64-2.67 (-1.36%) ▼|MSFT509.22-6.95 (-1.35%) ▼|MU1,053.98-28.30 (-2.61%) ▼|NEE75.49-0.59 (-0.78%) ▼|NFLX69.23-1.92 (-2.69%) ▼|NKE36.39+0.64 (+1.79%) ▲|NOW131.45-4.17 (-3.07%) ▼|NVDA228.86+3.79 (+1.68%) ▲|ORCL132.60-4.50 (-3.28%) ▼|PEP128.50-0.13 (-0.10%) ▼|PFE28.72+0.05 (+0.17%) ▲|PG149.03+2.80 (+1.91%) ▲|PLTR187.48-2.19 (-1.15%) ▼|PM193.76+3.28 (+1.72%) ▲|QCOM187.48-14.49 (-7.17%) ▼|RTX187.66-1.74 (-0.92%) ▼|SBUX95.27+0.41 (+0.43%) ▲|SCHW98.30-0.73 (-0.74%) ▼|SO82.35-0.53 (-0.64%) ▼|SPG204.53-0.29 (-0.14%) ▼|T24.90-0.48 (-1.89%) ▼|TMO678.60+3.60 (+0.53%) ▲|TMUS166.45+1.02 (+0.62%) ▲|TSLA357.45-14.66 (-3.94%) ▼|TXN278.31+0.24 (+0.09%) ▲|UBER68.16-1.46 (-2.10%) ▼|UNH377.83+1.24 (+0.33%) ▲|UNP274.10+0.31 (+0.11%) ▲|UPS94.25+0.29 (+0.31%) ▲|USB58.78-0.55 (-0.93%) ▼|V367.74+0.36 (+0.10%) ▲|VZ46.68-0.40 (-0.85%) ▼|WFC80.81-2.16 (-2.60%) ▼|WMT108.73+0.75 (+0.69%) ▲|XOM162.52+1.93 (+1.20%) ▲|
15.7 C
New York
Tuesday, September 29, 2026

Tag: source

newssourceFORcompanyinformationcontent1releasesmarket

Harness Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance Parkinson’s Disease Programme

Grant awarded through the Parkinson's Disease Therapeutics Pipeline Program to support advancement of Harness' new programme targeting GCase and LIMP2 for Parkinson's disease

Progress on share buyback programme

Progress on share buyback programme

Equinor ASA: Share buy-back – second tranche for 2026

Please see below information about transactions made under the second tranche of the 2026 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO).

Transparency Declaration Notification

Regulatory information

Notification on manager’s related party transactions

Apranga APB has received notification on the transactions in issuer's securities concluded by Minvista UAB, legal entity closely related to member of the board Darius Mockus (see attachment).

Kalmar selects Syncron to strengthen parts planning and advance aftermarket performance

Kalmar has partnered with Syncron to implement its parts planning solution.

Vocalbeats.AI Joins SuperAI 2026 as Gold Sponsor

SINGAPORE, June 09, 2026 (GLOBE NEWSWIRE) -- Vocalbeats.AI, a Singapore-based AI-powered audio company, today announces its Gold Sponsorship of SuperAI 2026, taking place on 10–11 June 2026 at Marina Bay Sands, Singapore.

Equinor ASA: Tilbakekjøp av egne aksjer – andre transje for 2026

Nedenfor følger informasjon om transaksjoner foretatt under andre transje av Equinor ASAs (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO) tilbakekjøpsprogram for 2026.

VAALCO Energy, Inc. Announces Baobab Field Production Resumes After Successful FPSO Refurbishment

HOUSTON, June 09, 2026 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE: EGY, LSE: EGY) (“Vaalco” or the “Company”) announced that the Baobab field on CI-40 block, offshore Côte d’Ivoire is back online following the successful Baobab Ivoirien Floating Production Storage and Offloading vessel (“FPSO”) refurbishment.

Notice of Convening the Annual General Meeting of Shareholders of Arco Vara AS

NOTICE OF THE ANNUAL GENERAL MEETING, ITS AGENDA AND PROPOSED RESOLUTIONS

Arco Vara AS aktsionäride korralise üldkoosoleku kokkukutsumise teade

AKTSIONÄRIDE KORRALISE ÜLDKOOSOLEKU KUTSE, PÄEVAKORD JA ETTEPANEKUD

TGS Awarded Offshore Wind Site Characterization Contract in Europe

OSLO, Norway (9 June 2026) – TGS, a leading provider of energy data and intelligence, is pleased to announce the award of an offshore wind site characterization contract in Europe. The Ramform Vanguard is scheduled to commence data acquisition in early August, and the contract has a duration of approximately three weeks.

Defiance Launches MUZ: The First 2X Short ETF for Micron Technology, Inc.

Defiance Launches MUZ: The First 2X Short ETF for Micron Technology, Inc.

[Latest] Global Generic Drug Market Size/Share Worth USD 926.54 Billion by 2034 at a 6.55% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends,...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Generic Drug Market size & share revenue was valued at approximately USD 491.35 Billion in 2024 and is expected to reach USD 519.11 Billion in 2025 and is expected to reach around USD 926.54 Billion by 2034, at a CAGR of 6.55% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Alkem Laboratories Limited, Teva Pharmaceutical Industries Limited, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Mylan N.V., Lupin Limited, STADA Arzneimittel AG, Hikma Pharmaceuticals plc, Torrent Pharmaceuticals Ltd., Endo International plc, Aurobindo Pharma Limited, Sawai Pharmaceutical Co. Ltd., Mallinckrodt plc, Amneal Pharmaceuticals Inc and others. 
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Generic Drug Market size & share revenue was valued at approximately USD 491.35 Billion in 2024 and is expected to reach USD 519.11 Billion in 2025 and is expected to reach around USD 926.54 Billion by 2034, at a CAGR of 6.55% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Alkem Laboratories Limited, Teva Pharmaceutical Industries Limited, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Mylan N.V., Lupin Limited, STADA Arzneimittel AG, Hikma Pharmaceuticals plc, Torrent Pharmaceuticals Ltd., Endo International plc, Aurobindo Pharma Limited, Sawai Pharmaceutical Co. Ltd., Mallinckrodt plc, Amneal Pharmaceuticals Inc and others.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSource

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers